The key to treating rare liver cancer may lie in immunotherapy directed against the cancer fusion protein.

Published Date: 20 Mar 2024

If surgery is not performed quickly to treat fibrolamellar carcinoma (FLC), a rare form of liver cancer, the prognosis is not good. One single genetic mutation that results in the production of a fusion protein is the cause of the illness. researchers at St. Jude Youth Foundation.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot